University of Idaho - I Banner
A student works at a computer

VandalStar

U of I's web-based retention and advising tool provides an efficient way to guide and support students on their road to graduation. Login to VandalStar.

Hepatitis C

The U.S. Department of Health & Human Services (HHS) reports that despite effective treatment options, “hepatitis C rates nearly tripled from 2011 to 2018.” The same report identifies higher rates of substance use disorder, injection drug use and homelessness as factors in the increase. 

Hepatitis C (HCV) care can easily be delivered by primary care providers with appropriate training and guidance. By learning how to treat this curable disease, you can help your patients avoid complications such as cirrhosis and help prevent the spread of HCV. 

Led by a panel of subject matter experts in family medicine, hepatology, gastroenterology, pharmacology and HIV care, our series will help build your confidence as you learn and develop best practices for treating HCV.

Participating also helps you connect with other peers statewide to identify approaches and resources for advancing patient care and to get insightful feedback on patient cases. These sessions are designed to be collaborative, engaging and immediately applicable to your practice.

When

Date: April 12 - Sept. 27, 2021

Time: Noon to 1 p.m. Mountain time, 11 a.m. to noon Pacific time

Virtual sessions meet second and fourth Mondays each month.

Each session will include a brief didactic overview of the topic followed by participant-initiated, case-based discussion.

Series Kickoff Monday, April 12, 2021 with Special Guests

Sanjeev Arora

Sanjeev Arora, MD, MACP, FACG

Founder and Director of Project ECHO

In addition to his leadership and scholarship advancing Project ECHO around the globe, Dr. Arora has over 15 years of experience managing viral hepatitis, is a Distinguished Professor of Medicine, Director of the Office of Clinical Affairs and Executive Vice Chair for the Department of Internal Medicine at the University of New Mexico Health Sciences Center in Albuquerque.

Terry Box

Terry Box, MD

Associate Professor, Department of Internal Medicine at the University of Utah School of Medicine

Dr. Box is an award-winning gastroenterologist in Salt Lake City, Utah and is a member of the American Liver Foundation’s National Medical Advisory Committee. He is also a Huntsman Cancer Institute (HCI) investigator and a member of HCI’s Gastrointestinal Cancer Program. Dr. Box was the University of Utah’s ECHO facilitator for its Hepatitis C series.

Magni Hamso

Magni Hamso, MD, MPH

Medical Director, Division of Medicaid, Idaho Department of Health & Welfare

Dr. Hamso was first introduced to Project ECHO when she attended the University of Utah’s Hepatitis C series. She has been a MAT-waiver trainer with ECHO Idaho since 2018 and has been critical to ECHO Idaho’s Hepatitis C series’ launch.

Audience

The target audience is primary care providers (MD, PA, NP, RN, etc.), but all clinicians are welcome.

Cost

Participation in ECHO Idaho is free for clinicians and organizations.

Register

Please register here for the ongoing sessions.

Once you register, you’ll receive convenient, day-of Zoom access direct to your inbox – join us as your schedule allows.

Not a fan of emails? Sign up for day-of reminder texts for this session.

Remember, you may claim CME/CE up to 1.0 AMA PRA Category 1 Credit™ and receive a certificate by completing a survey for each live session attended. See “No-Cost CE and CME” below for more information.

Benefits

  • Professional Development: Participants gain new skills and competencies for managing patients.
  • Creating Community: Clinician teams can increase professional satisfaction and decrease isolation, thus creating a sense of community.
  • Increased Patient Satisfaction: Patients can continue to work with their trusted clinician instead of traveling long distances to be seen by a specialist.
  • Improved Quality of Care: Healthcare professionals who participate in ECHO increase their knowledge and self-efficacy.
  • No-Cost CE/CME: ECHO Idaho offers free continuing medical education and continuing education units for attending live sessions. To claim continuing education credit and provide feedback, please complete this post-session evaluation survey.

The University of Idaho, WWAMI Medical Education Program is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Idaho, WWAMI Medical Education Program designates each live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PAs, NPs, RNs, CADC/ACADC/CPS, Social Workers, Counselors and Therapists and others: Learn how ECHO Idaho can help support your continuing education needs here.


ECHO Idaho is led by the University of Idaho and the WWAMI Medical Education Program.

Hepatitis C Facts

Hepatitis C is a leading cause of chronic liver disease and liver-related mortality.

  • Between 2014 and 2018, acute hepatitis C cases increased 71% nationwide, with two-thirds of cases occurring among persons aged 20–39 years, the age-group most impacted by the opioid crisis.
  • Because the disease can develop without symptom onset, it’s estimated that only 60% of people living with hepatitis C are aware of their status.
  • Screening rates remain low in rural areas throughout Idaho, despite the fact that the CDC encourages all adults to be screened for the disease at least once and cites significant improvement in patient outcomes when the disease is diagnosed and treated early.

Contact Project ECHO

Physical Address:

Idaho Water Center
322 E. Front Street, Ste. 222
Boise, ID 83702

Phone: 208-364-4698

Fax: 208-364-3178

Email: echoidaho@uidaho.edu